Clinical Trial Update: A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics, pharmacodynamics, and safety of BR1400-1, BR1400-2, and BR1400-3 in healthy adult volunteers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BR1400-1
• BR1400-2
• BR1400-3

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED